Carrier of Group B streptococcus
ICD-10 Z22.330 is a billable code used to indicate a diagnosis of carrier of group b streptococcus.
Z22.330 identifies individuals who are carriers of Group B streptococcus (GBS), a bacterium that can be found in the intestines and the lower genital tract. While GBS is typically harmless in adults, it can pose significant risks during pregnancy, potentially leading to serious infections in newborns. Understanding the social determinants of health is crucial, as factors such as access to healthcare, socioeconomic status, and education can influence screening and preventive measures. Preventive care for GBS carriers includes routine screenings during pregnancy, particularly in the third trimester, to assess the risk of transmission to the infant. Screening protocols and aftercare strategies are essential to mitigate risks associated with GBS, especially in vulnerable populations. Documentation of carrier status is vital for ensuring appropriate management and follow-up care, which may include antibiotic prophylaxis during labor to prevent neonatal infection.
Documentation should include screening results, risk factors, and any preventive measures taken.
Routine prenatal visits where GBS screening is performed.
Consideration of social determinants such as access to prenatal care and education about GBS.
Population-level data on GBS prevalence and outcomes, including tracking of screening rates.
Public health initiatives aimed at increasing awareness and screening for GBS in pregnant populations.
Focus on health equity and access to care for diverse populations.
Used during routine prenatal visits to screen for GBS.
Document the screening results and any follow-up care provided.
Primary care providers should ensure proper education on GBS risks.
Being a carrier of GBS is significant, especially during pregnancy, as it can lead to serious infections in newborns. Screening and appropriate management are crucial to prevent transmission.
